Skip to Main Content

Paper Details

Phase II Single-arm Study of Durvalumab and Tremelimumab with Concurrent Radiotherapy in Patients with Mismatch Repair-proficient Metastatic Colorectal Cancer.
Clin Cancer Res
47
2021
Author NameAffiliation
Travis J HollmannMemorial Sloan Kettering Cancer Center
Krishna JuluruMemorial Sloan Kettering Cancer Center
Stephen B SolomonMemorial Sloan Kettering Cancer Center
  • 1 - 3

Datasets

Release 1.2